Redhill Biopharma’s First Half of 2024: A Look at the Good, the Bad, and the Exciting!
A Transformed RedHill: Strengthened Cash Balance and Control Executing on a Value-Driven Focus U.S. Government Collaborations and Addressing Underserved Indications RedHill Biopharma, a pharmaceutical company focused on developing innovative drugs for various medical conditions, has recently undergone a significant transformation. With a strengthened cash balance and control over their destiny following the Termination Agreement with…